CH625223A5 - - Google Patents

Download PDF

Info

Publication number
CH625223A5
CH625223A5 CH1551176A CH1551176A CH625223A5 CH 625223 A5 CH625223 A5 CH 625223A5 CH 1551176 A CH1551176 A CH 1551176A CH 1551176 A CH1551176 A CH 1551176A CH 625223 A5 CH625223 A5 CH 625223A5
Authority
CH
Switzerland
Prior art keywords
group
formula
compound
carbon atoms
represent
Prior art date
Application number
CH1551176A
Other languages
German (de)
English (en)
Inventor
John Bedford Stenlake
Nirmal Chandra Dhar
Roger David Waigh
George Henry Dewar
John Urwin
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26265501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH625223(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB4502876A external-priority patent/GB1579822A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH625223A5 publication Critical patent/CH625223A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH1551176A 1975-12-10 1976-12-09 CH625223A5 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5058975 1975-12-10
GB4502876A GB1579822A (en) 1976-10-29 1976-10-29 Tetrahydroisoquinolinium muscle relaxants

Publications (1)

Publication Number Publication Date
CH625223A5 true CH625223A5 (ru) 1981-09-15

Family

ID=26265501

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1551176A CH625223A5 (ru) 1975-12-10 1976-12-09

Country Status (24)

Country Link
US (1) US4179507A (ru)
JP (1) JPS6043342B2 (ru)
AT (1) AT365579B (ru)
AU (1) AU506657B2 (ru)
CA (1) CA1075241A (ru)
CH (1) CH625223A5 (ru)
CY (1) CY1217A (ru)
DD (1) DD128320A5 (ru)
DE (1) DE2655883A1 (ru)
DK (1) DK149751C (ru)
FI (1) FI61485C (ru)
FR (1) FR2334359A1 (ru)
HK (1) HK35084A (ru)
IE (1) IE44569B1 (ru)
IL (1) IL51074A (ru)
IT (1) IT1188908B (ru)
KE (1) KE3361A (ru)
LU (1) LU76355A1 (ru)
MC (1) MC1119A1 (ru)
MY (1) MY8500287A (ru)
NL (1) NL178688C (ru)
NZ (1) NZ182847A (ru)
SE (1) SE434154B (ru)
SU (1) SU718008A3 (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235906A (en) 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
US4315935A (en) * 1980-04-14 1982-02-16 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use
US4317826A (en) * 1980-05-27 1982-03-02 Smithkline Corporation N,N'-Bis[substituted-1,2,3,4 tetrahydroisoquinolyl]disulfonylimides and antiallergic compositions and method of use
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
GB9015473D0 (en) * 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
US5684154A (en) * 1996-02-16 1997-11-04 Abbott Laboratories Process for the preparation and isolation of atracurium besylate
ATE254107T1 (de) * 1997-03-25 2003-11-15 Avera Pharmaceuticals Inc Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
EP2125742A2 (en) * 2007-03-08 2009-12-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
AU2008231470A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
AU2008243749B2 (en) * 2007-05-01 2012-05-03 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
US8357807B2 (en) * 2007-05-01 2013-01-22 Chemagis Ltd. Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
WO2008155752A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
CN101337935B (zh) * 2007-07-06 2011-01-12 江苏恒瑞医药股份有限公司 一种用两相萃取法纯化苯磺酸阿曲库铵的方法
CN101337936B (zh) * 2007-07-06 2011-03-23 江苏恒瑞医药股份有限公司 一种用柱色谱法纯化苯磺酸阿曲库铵的方法
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
EP2197848A1 (en) * 2007-10-29 2010-06-23 Chemagis Ltd. Novel r,r'-atracurium salts
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
EA022030B1 (ru) * 2009-04-14 2015-10-30 Глаксо Груп Лимитед Способ получения 1-[2-(2-хлор-4-формил-5-метоксифенилкарбамоил)этил]пиперидин-4-илового эфира бифенил-2-илкарбаминовой кислоты
WO2011022491A1 (en) 2009-08-19 2011-02-24 Cornell University Cysteine for physiological injection
EP2514754B1 (en) 2011-04-08 2013-08-21 King Saud University 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
CN102249998B (zh) * 2011-06-20 2013-09-25 浙江仙琚制药股份有限公司 一种制备顺苯磺酸阿曲库铵的方法
CN102898370A (zh) * 2012-11-11 2013-01-30 苏州二叶制药有限公司 注射用顺苯磺阿曲库铵
WO2018193463A1 (en) * 2017-04-21 2018-10-25 Neon Laboratories Limited An improved process for the preparation of tetrahydroisoquinoline compounds
CN114181147A (zh) * 2021-12-27 2022-03-15 上海药坦药物研究开发有限公司 一种苯磺阿曲库铵的处理方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB1125619A (en) * 1965-11-15 1968-08-28 Wellcome Found Derivatives of bis-isoquinolines

Also Published As

Publication number Publication date
DD128320A5 (de) 1977-11-09
ATA908476A (de) 1981-06-15
CY1217A (en) 1984-04-06
JPS5277069A (en) 1977-06-29
NL7613695A (nl) 1977-06-14
NZ182847A (en) 1979-06-08
NL178688B (nl) 1985-12-02
FR2334359A1 (fr) 1977-07-08
SE434154B (sv) 1984-07-09
KE3361A (en) 1984-02-17
NL178688C (nl) 1986-05-01
AU2037576A (en) 1978-06-15
AT365579B (de) 1982-01-25
US4179507A (en) 1979-12-18
DK149751B (da) 1986-09-22
IL51074A (en) 1980-05-30
AU506657B2 (en) 1980-01-17
FI61485B (fi) 1982-04-30
IL51074A0 (en) 1977-02-28
IE44569B1 (en) 1982-01-13
LU76355A1 (ru) 1977-06-24
IE44569L (en) 1977-06-10
DE2655883C2 (ru) 1990-02-01
DE2655883A1 (de) 1977-06-23
CA1075241A (en) 1980-04-08
MC1119A1 (fr) 1977-08-12
JPS6043342B2 (ja) 1985-09-27
MY8500287A (en) 1985-12-31
DK149751C (da) 1987-03-23
IT8048000A1 (it) 1981-08-25
IT1188908B (it) 1988-01-28
SU718008A3 (ru) 1980-02-25
IT8048000A0 (it) 1980-02-25
FR2334359B1 (ru) 1981-10-16
DK553676A (da) 1977-06-11
FI61485C (fi) 1982-08-10
FI763543A (ru) 1977-06-11
SE7613824L (sv) 1977-06-11
HK35084A (en) 1984-04-27

Similar Documents

Publication Publication Date Title
CH625223A5 (ru)
DE1620262B2 (de) Spiro [4.5] decanderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE1018422B (de) Verfahren zur Herstellung basisch substituierter Heterocyclen
DE1911464C3 (de) 3,4-Dihydroisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE2833505A1 (de) Tetrahydro-isochinolin-derivate, verfahren zu deren herstellung und mittel enthaltend die derivate
DE3013906A1 (de) Substituierte (alpha) -aminocarbonyl-l-benzyl-3,4-dihydro-isochinoline, verfahren zu deren herstellung und deren verwendung
DE1695111B1 (de) Indolderivate
DE2851416A1 (de) 2-(4-biphenylyl)-n-(diethylaminoalkyl)- propionamide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
GB1579822A (en) Tetrahydroisoquinolinium muscle relaxants
DE3007710C2 (de) 5,6;8,9-Tetrahydro-7H-dibenz(d,f)azonin-derivate, Verfahren zu deren Herstellung und Arzneimittel
CH493467A (de) Verfahren zur Herstellung von Dibenzosuberenderivaten
DE2034588C3 (de) 6,7-Dimethoxy-4-benzylisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
DE2406490C2 (de) 1,4-Dihydro-3(2H)-isochinolinonverbindungen und ihre Salze, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel
DE1620151B1 (de) 10-Piperazino-dibenzo(a,d)cycloheptadienderivate und Verfahren zu ihrer Herstellung
DE2634337B2 (de) Triaminoandrostan-Derivate, deren Säureadditionssalze und quaternären Salze sowie ein Verfahren ztfr Herstellung dieser Verbindungen
DE2034587A1 (de) Neue, insbesondere sympathikolytische pharmazeutische Zusammensetzungen auf der Basis von Isochinolinen und neue substituierte Isochinoline
DE1092476B (de) Verfahren zur Herstellung von Phenthiazinderivaten
DE2835987A1 (de) 3-amino-17a-aza-d-homo-5 alpha -androstanderivate und quaternaere salze davon sowie verfahren zu ihrer herstellung
DE2751905C2 (ru)
DE2811849C2 (ru)
DE1670633A1 (de) Mittel zur Ausloesung fibrinolytischer Aktivitaet bei Saeugetieren
DE1620151C (de) 10 Piperazino dibenzo eckige Klammer auf a,d eckige Klammer zu cycloheptadien derivate und Verfahren zu ihrer Herstel lung
DE1182237B (de) Verfahren zur Herstellung von 10-[4'-Hydroxy-4'-hydroxyalkylpiperidinoalkyl]-phenthiazin-derivaten
DE2522785A1 (de) Analgetische masse

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate filed

Free format text: IKS 45342/871231, 951115

SPCF Supplementary protection certificate filed

Free format text: IKS 45342/871231, 951115

PK Correction

Free format text: IKS 45342/830620, 951115

SPCG Supplementary protection certificate granted

Free format text: IKS 45342/830620, 951115, EXPIRES:19980620

PL Patent ceased